HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

Revlon Q3: Improvement in sales returns and higher shipments of beauty care, primarily women's hair color, boosted U.S. sales during the third quarter 19.7% to $190.9 mil., Revlon says during a Q3 earnings call Nov. 6. However, Vital Radiance negatively impacted sales by $15 mil., the firm notes. As part of a recovery plan for 2008, Revlon will introduce a slew of new products in the first half, including ColorStay Minerals, "the first-ever longwearing minerals collection in the mass market" as well as Revlon Custom Creations Foundation and Almay foundations, makeup remover and other products. Net sales grew 11% to $339.7 mil., and the firm experienced a net loss of $10.4 mil. compared with a net loss of $100.5 mil. in the prior-year quarter...

You may also be interested in...

Inter Parfums To Launch Creations In One Year At Brooks Brothers Locations

Personal-care products developed under an agreement between Inter Parfums and Brooks Brothers are expected to roll out in November 2008 to the clothier's U.S. retail stores, with international distribution beginning in 2009, according to a Nov. 27 announcement

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts